# Simvastatin as an add-on Treatment to Copaxone for the Treatment of Relapsing Multiple Sclerosis

> **NCT00429442** · PHASE3 · WITHDRAWN · sponsor: **Anna Tsakiri**

## Conditions studied

- Relapsing Remitting Multiple Sclerosis

## Interventions

- **DRUG:** Simvastatin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00429442
- **Lead sponsor:** Anna Tsakiri
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-03
- **Primary completion:** —
- **Final completion:** 2011-03
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2014-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00429442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00429442, "Simvastatin as an add-on Treatment to Copaxone for the Treatment of Relapsing Multiple Sclerosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00429442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*